Curevo Vaccine
Charlie is the co-founder of Adjuvant Capital, which manages a $300m venture capital fund focused on life sciences technologies for high-burden public health challenges. Previously, he was with the Global Health Investment Fund, an experimental investment vehicle formed by JP Morgan and the Bill & Melinda Gates Foundation. Prior to his career investing in global health research and development, he was a private equity investor at Artemis.
This person is not in the org chart
This person is not in any offices
Curevo Vaccine
Reach out to the team at Curevo Vaccine to learn about the vaccine research we perform to bring them to market.